Medpace Holdings Revenue 2014-2023 | MEDP
Medpace Holdings annual/quarterly revenue history and growth rate from 2014 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medpace Holdings revenue for the quarter ending December 31, 2023 was $0.498B, a 26.47% increase year-over-year.
- Medpace Holdings revenue for the twelve months ending December 31, 2023 was $1.886B, a 29.17% increase year-over-year.
- Medpace Holdings annual revenue for 2023 was $1.886B, a 29.17% increase from 2022.
- Medpace Holdings annual revenue for 2022 was $1.46B, a 27.8% increase from 2021.
- Medpace Holdings annual revenue for 2021 was $1.142B, a 23.38% increase from 2020.
| Medpace Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,886 |
| 2022 | $1,460 |
| 2021 | $1,142 |
| 2020 | $926 |
| 2019 | $861 |
| 2018 | $705 |
| 2017 | $436 |
| 2016 | $422 |
| 2015 | $359 |
| 2014 | $326 |
| 2013 | $273 |
| Medpace Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $498 |
| 2023-09-30 | $492 |
| 2023-06-30 | $461 |
| 2023-03-31 | $434 |
| 2022-12-31 | $394 |
| 2022-09-30 | $384 |
| 2022-06-30 | $351 |
| 2022-03-31 | $331 |
| 2021-12-31 | $309 |
| 2021-09-30 | $296 |
| 2021-06-30 | $278 |
| 2021-03-31 | $260 |
| 2020-12-31 | $260 |
| 2020-09-30 | $230 |
| 2020-06-30 | $205 |
| 2020-03-31 | $231 |
| 2019-12-31 | $230 |
| 2019-09-30 | $216 |
| 2019-06-30 | $214 |
| 2019-03-31 | $201 |
| 2018-12-31 | $192 |
| 2018-09-30 | $179 |
| 2018-06-30 | $170 |
| 2018-03-31 | $163 |
| 2017-12-31 | $113 |
| 2017-09-30 | $111 |
| 2017-06-30 | $106 |
| 2017-03-31 | $107 |
| 2016-12-31 | $108 |
| 2016-09-30 | $108 |
| 2016-06-30 | $106 |
| 2016-03-31 | $100 |
| 2015-12-31 | |
| 2015-09-30 | $92 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.576B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.503B | 15.75 |
| Cencora (COR) | United States | $44.240B | 17.25 |
| ICON (ICLR) | Ireland | $26.547B | 25.06 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Avantor (AVTR) | United States | $17.124B | 25.21 |
| CochLear (CHEOY) | Australia | $14.770B | 0.00 |
| Revvity (RVTY) | United States | $13.241B | 23.23 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.178B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.562B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 22.93 |
| Solventum (SOLV) | United States | $10.784B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.508B | 48.62 |
| Organon (OGN) | United States | $5.568B | 5.28 |
| Bausch + Lomb (BLCO) | Canada | $5.269B | 21.11 |
| Doximity (DOCS) | United States | $4.449B | 33.12 |
| PACS (PACS) | United States | $4.257B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.440B | 31.48 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $2.979B | 31.21 |
| GoodRx Holdings (GDRX) | United States | $2.728B | 103.86 |
| Progyny (PGNY) | United States | $2.550B | 43.90 |
| Premier (PINC) | United States | $2.383B | 8.92 |
| AMN Healthcare Services Inc (AMN) | United States | $2.287B | 9.06 |
| NovoCure (NVCR) | Jersey | $2.265B | 0.00 |
| Agilon Health (AGL) | United States | $2.180B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.992B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.647B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.348B | 0.00 |
| Embecta (EMBC) | United States | $0.793B | 5.39 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.690B | 7.32 |
| Auna S.A (AUNA) | Luxembourg | $0.648B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.566B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.434B | 43.30 |
| MultiPlan (MPLN) | United States | $0.405B | 0.00 |
| ModivCare (MODV) | United States | $0.382B | 7.15 |
| LifeMD (LFMD) | United States | $0.351B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 18.67 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| Sharecare (SHCR) | United States | $0.275B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.124B | 41.67 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| Oncology Institute (TOI) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |